Skip to main
SMLR
SMLR logo

Semler Scientific (SMLR) Stock Forecast & Price Target

Semler Scientific (SMLR) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Semler Scientific Inc. demonstrates a positive financial outlook due to its unique niche in providing technology solutions that enhance the clinical effectiveness and efficiency of healthcare providers, which is supported by its proprietary QuantaFlo vascular-testing product. The potential upside from recent merger-arbitrage opportunities highlights a significant discount to implied deal value, suggesting compelling growth prospects if the transaction with Strive progresses as anticipated. Furthermore, the company’s robust cash flows generated from its healthcare technology solutions facilitate its ability to invest in bitcoin, thereby enhancing its overall asset diversification and financial stability.

Bears say

Semler Scientific faces a negative outlook primarily due to significant market skepticism regarding the implications of its strategic partnership with Strive, which may pressure the company's valuations if Strive's share price declines further. Additionally, the interconnectedness of the deal's economics with bitcoin's performance poses risks, particularly as the announcement coincided with a downturn in bitcoin prices. This scenario highlights potential volatility in Semler's financial stability stemming from its investment in bitcoin as a treasury reserve asset, undermining investor confidence.

Semler Scientific (SMLR) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Semler Scientific and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Semler Scientific (SMLR) Forecast

Analysts have given Semler Scientific (SMLR) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Semler Scientific (SMLR) has a Strong Buy consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $74.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $74.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Semler Scientific (SMLR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.